Search

everythinglearnresearchcommunity

for

Search:↓

TNF-α blockers and IL inhibitors improve symptoms in most patients with severe scalp condition, but more research is needed.

5-alpha reductase inhibitors and spironolactone don't increase gynecological tumor risk, glucagon-like-peptide-1 receptor agonists may increase alopecia risk, sanitary pads can cause dermatitis, early hidradenitis suppurativa intervention is crucial for Hispanic patients, community education boosts skin cancer awareness, metformin may improve skin cancer survival, LNG-IUDs can increase acne risk, machine learning accurately detects basal cell carcinoma, JAK-inhibitors may raise miscarriage risk, inclusive skincare ads affect those with darker skin, and CCCA in Black women might involve autoimmunity.

Combining light therapy with certain substances improves hair growth in people with hair loss.

These migraine prevention drugs can cause side effects like constipation, hair loss, injection site reactions, fatigue, and sometimes unexpected issues like Raynaud's phenomenon and weight gain.

Simvastatin/ezetimibe may help some patients with severe alopecia areata regrow hair.

Pimecrolimus reduces the effectiveness of stem cell therapy for atopic dermatitis.

Significant progress was made in understanding androgen excess disorders, but much is still unknown.

Childhood Alopecia Areata causes hair loss and requires varied treatments, with psychological support being crucial.

Stem cell therapy from umbilical cords may help treat atopic dermatitis.

Minoxidil is the main over-the-counter treatment for hair loss, with other options like finasteride, latanoprost, retinoic acid, antioxidants, biotin, nutraceuticals, and platelet-rich plasma therapy also showing promise.

Hawthorn-probiotic postbiotic may relieve constipation in elderly.

Dermatology drug use in Denmark mostly follows expected patterns, but further checks are needed for any misuse.

Microneedles could revolutionize pediatric medicine by offering painless drug delivery, but more development is needed.

Smart biomaterials and dressings show promise in treating chronic skin diseases by improving drug delivery and minimizing side effects.

Ac-GFFY-IGF peptide is a promising, safe, and effective treatment for hair loss, better than current options.

Newer GLP-1 drugs like semaglutide may cause hair loss.

The supplement significantly improves hair density and appearance in people with hair loss.

The medicine baricitinib was found to notably improve hair regrowth in alopecia areata, but more research is needed on its side effects and other treatments.

Using stem cell-enriched fat injections before hair transplant surgery can result in less hair loss and thicker hair.

Human hair follicle stem cells help repair tendon injuries.

The convention highlighted the importance of comprehensive patient care and early diagnosis in dermatology.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Abnormal ECM and immune cell interactions can cause skin diseases.

Targeting androgen receptors shows promise for treating triple-negative breast cancer, but more research is needed.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

New hair growth corticosterone levels are higher in diabetic mice, indicating long-term stress.

The supplement helps improve hair growth and reduce hair shedding.

Isotretinoin can cause serious birth defects and needs careful use, especially in pregnant women.

Both patients and physicians are often dissatisfied with the control of systemic lupus erythematosus and lupus nephritis.

Certain natural and synthetic compounds may help treat inflammatory skin diseases by targeting a specific signaling pathway.